Desalted Salicornia europaea powder and its active constituent, trans-ferulic acid, exert anti-obesity effects by suppressing adipogenic-related factors

Pharm Biol. 2018 Dec;56(1):183-191. doi: 10.1080/13880209.2018.1436073.

Abstract

Context: Salicornia europaea (Amaranthaceae) (SE) has been shown to reduce obesity, but it remains a problem as a food supplement because of its high salt content (25-35% NaCl).

Objectives: This study investigated the anti-obesity effects and mechanism of action of desalted SE powder (DSP).

Materials and methods: Sprague-Dawley rats (n = 50) were divided into a normal control group (NC), a high-fat diet (HFD)-induced obesity control group (HFD), and HFD groups co-administered DSP (250 and 500 mg/kg) or Garcinia cambogia (Clusiaceae) extract (GE, 200 mg/kg, standard control) orally each day for 12 weeks.

Results: The body weight was significantly reduced by co-administration of DSP (596.51 ± 19.84 kg, 4.60% and 562.08 ± 9.74 kg, 10.10%, respectively) and GE (576.00 ± 11.29 kg, 7.88%) relative to the HFD group (625.25 ± 14.02 kg) and was accompanied by reduced abdominal fat mass, and serum lipid levels, with no effects on feed intake. To find the underlying mechanism of the anti-obesity effects, trans-ferulic acid (TFA) was identified as the main ingredient and investigated with regard to whether it attenuated adipogenesity in 3T3L-1 cells. DSP-derived TFA suppressed adipocyte differentiation and accumulation of intracellular lipids. TFA also down-regulated the adipogenesis-related gene expression of sterol regulatory element-binding protein 1, peroxisome proliferator-activated receptor γ, CCAAT/enhancer binding protein-α and fatty acid synthase.

Conclusions: These findings suggest that DSP may be considered for use as a food supplement intent of controlling obesity through its antiobesity and antiadipogenic properties.

Keywords: 3T3L-1 cells; Desaltation; abdominal fat mass; adipogenesis.

MeSH terms

  • 3T3-L1 Cells
  • Adipogenesis / drug effects*
  • Adipogenesis / physiology
  • Animals
  • Anti-Obesity Agents / isolation & purification
  • Anti-Obesity Agents / pharmacology
  • Anti-Obesity Agents / therapeutic use*
  • Body Weight / drug effects
  • Body Weight / physiology
  • Chenopodiaceae*
  • Coumaric Acids / isolation & purification
  • Coumaric Acids / pharmacology
  • Coumaric Acids / therapeutic use*
  • Dose-Response Relationship, Drug
  • Male
  • Mice
  • Obesity / drug therapy*
  • Obesity / metabolism
  • Plant Extracts / isolation & purification
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Anti-Obesity Agents
  • Coumaric Acids
  • Plant Extracts
  • ferulic acid

Grants and funding

This research was supported by an export strategy technology development project (114087-2) of the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea and also supported by IPET, Korea through High Value-added Food Technology Development Program, funded by Ministry of Agriculture, Food and Rural Affairs (MAFRA) (116018-03-3-SB010).